De Novo device
Caption Guidance
Bay Labs, Inc. · Image Acquisition And/Or Optimization Guided By Artificial Intelligence (QJU, Class II) · First FDA decision Feb 7, 2020, newest Feb 7, 2020
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
2
Naming "Caption Guidance"
MAUDE reports
0
Brand "Caption Guidance", since 2015
PubMed studies
0
Mentioning "Caption Guidance"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Caption GuidanceNew device typeBreakthroughDe Novo
DEN190040 · Decided Feb 7, 2020 · 164 days after receipt
Device type: Image Acquisition And/Or Optimization Guided By Artificial Intelligence (QJU) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Image-Guided Lumbar Decompression for Lumbar Spinal StenosisNational determinationOn the books150.13Updated Nov 5, 2026
- Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal StenosisNational analysisReview closedCAG-00433RUpdated Sep 21, 2026
- Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal StenosisNational analysisReview closedCAG-00433NUpdated Sep 21, 2026
- Breast Biopsy (Percutaneous Image Guided) for Palpable LesionsNational analysisReview closedCAG-00074NUpdated Sep 14, 2026
- Percutaneous Image-Guided Breast BiopsyNational determinationOn the books220.13Updated Sep 9, 2025
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39851Palmetto GBAUpdated Oct 7, 2026
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39863Wellpoint FederalUpdated Jul 14, 2026
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39881Noridian Healthcare Solutions, LLCUpdated Oct 7, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Caption Guidance", any status and sponsor, newest update first.
- A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and InterpretationRecruiting
Caption Health, Inc.Not on our public-company list
NCT05992324 · 220 participants (planned) · Start Jul 17, 2023 · Primary completion Dec 31, 2024
Device: Caption LungAI · For: Shortness of Breath
Sites: New Haven, Connecticut; Chicago, Illinois; Greensboro, North Carolina · 4 sites in all
Caption Health, Inc.Not on our public-company list
NCT04203251 · 100 participants (planned) · Start Mar 2020 · Primary completion May 2020
Device: Caption Health Guidance Technology · For: Cardiac Disease
Sites: San Francisco, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Caption Guidance", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QJU
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Caption Guidance"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QJU.
- HeartFocusDeski · 510(k) 2026
- Caption GuidanceCaption Health · 510(k) 2020
- Lung GuidanceGE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · 510(k) 2026
- ThinkSono GuidanceThinkSono GmbH · 510(k) 2026
- UltraSight GuidanceUltrasight , Ltd. · 510(k) 2025
- Cardiac GuidanceCaption Health, Inc. · 510(k) 2025
- UltraSight AI GuidanceUltrasight, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.